{"entity":{"type":"insider","cik":"0001475714","url":"/insider/0001475714","json_url":"/insider/0001475714.json","name":"Williams Lewis T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":14,"first":"2014-10-30","last":"2026-02-18","span_basis":"filed_date"},"name_variants":[{"name":"Williams Lewis T","source":"filing","n_filings":14,"first_seen":"2014-10-30","last_seen":"2026-02-18"}],"transactions":[{"id":5845752,"accession":"0001104659-26-017176","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-017176","line_url":"/filing/0001104659-26-017176#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":82.42,"price_display":"82.42","price_state":"stated","total_value":1483560.0,"total_display":"1,483,560.00","total_whole":"1,483,560","shares_owned_after":7825.0,"shares_owned_after_display":"7,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-18","scope":"insider"},{"id":2181920,"accession":"0001209191-16-156690","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-156690","line_url":"/filing/0001209191-16-156690","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President, CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":50.4953,"price_display":"50.50","price_state":"stated","total_value":1514859.0,"total_display":"1,514,859.00","total_whole":"1,514,859","shares_owned_after":434192.0,"shares_owned_after_display":"434,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-23","filed_date":"2016-12-23","scope":"insider","n_lines":2},{"id":3352735,"accession":"0001209191-16-115383","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-115383","line_url":"/filing/0001209191-16-115383#line-4","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President, CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48121.0,"shares_display":"48,121","price_per_share":48.05,"price_display":"48.05","price_state":"stated","total_value":2312214.05,"total_display":"2,312,214.05","total_whole":"2,312,214","shares_owned_after":340528.0,"shares_owned_after_display":"340,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-21","filed_date":"2016-04-22","scope":"insider"},{"id":3352733,"accession":"0001209191-16-115383","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-115383","line_url":"/filing/0001209191-16-115383#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President, CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":550.0,"shares_display":"550","price_per_share":48.0,"price_display":"48.00","price_state":"stated","total_value":26400.0,"total_display":"26,400.00","total_whole":"26,400","shares_owned_after":340528.0,"shares_owned_after_display":"340,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-22","scope":"insider"},{"id":2884992,"accession":"0001209191-16-114592","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-114592","line_url":"/filing/0001209191-16-114592#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President, CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1405.0,"shares_display":"1,405","price_per_share":48.0,"price_display":"48.00","price_state":"stated","total_value":67440.0,"total_display":"67,440.00","total_whole":"67,440","shares_owned_after":340528.0,"shares_owned_after_display":"340,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-15","filed_date":"2016-04-18","scope":"insider"},{"id":3042782,"accession":"0001209191-16-114344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-114344","line_url":"/filing/0001209191-16-114344#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President, CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2725.0,"shares_display":"2,725","price_per_share":48.0,"price_display":"48.00","price_state":"stated","total_value":130800.0,"total_display":"130,800.00","total_whole":"130,800","shares_owned_after":340528.0,"shares_owned_after_display":"340,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-15","scope":"insider"},{"id":2508957,"accession":"0001209191-16-113575","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-113575","line_url":"/filing/0001209191-16-113575#line-4","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President, CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26852.0,"shares_display":"26,852","price_per_share":43.17,"price_display":"43.17","price_state":"stated","total_value":1159200.84,"total_display":"1,159,200.84","total_whole":"1,159,201","shares_owned_after":340528.0,"shares_owned_after_display":"340,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-06","filed_date":"2016-04-07","scope":"insider"},{"id":2508946,"accession":"0001209191-16-113575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-113575","line_url":"/filing/0001209191-16-113575#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President, CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25949.0,"shares_display":"25,949","price_per_share":43.0,"price_display":"43.00","price_state":"stated","total_value":1115807.0,"total_display":"1,115,807.00","total_whole":"1,115,807","shares_owned_after":340528.0,"shares_owned_after_display":"340,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-05","filed_date":"2016-04-07","scope":"insider"},{"id":3209111,"accession":"0001209191-16-111282","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-111282","line_url":"/filing/0001209191-16-111282#line-4","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President, CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14044.0,"shares_display":"14,044","price_per_share":40.02,"price_display":"40.02","price_state":"stated","total_value":562040.88,"total_display":"562,040.88","total_whole":"562,041","shares_owned_after":340528.0,"shares_owned_after_display":"340,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-30","filed_date":"2016-03-31","scope":"insider"},{"id":3209101,"accession":"0001209191-16-111282","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-111282","line_url":"/filing/0001209191-16-111282#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President, CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9215.0,"shares_display":"9,215","price_per_share":40.01,"price_display":"40.01","price_state":"stated","total_value":368692.15,"total_display":"368,692.15","total_whole":"368,692","shares_owned_after":340528.0,"shares_owned_after_display":"340,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-29","filed_date":"2016-03-31","scope":"insider"},{"id":2539332,"accession":"0000899243-16-015236","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-015236","line_url":"/filing/0000899243-16-015236#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23259.0,"shares_display":"23,259","price_per_share":36.01,"price_display":"36.01","price_state":"stated","total_value":837556.59,"total_display":"837,556.59","total_whole":"837,557","shares_owned_after":340352.0,"shares_owned_after_display":"340,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-02","filed_date":"2016-03-03","scope":"insider"},{"id":2208689,"accession":"0001123292-16-001685","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001123292-16-001685","line_url":"/filing/0001123292-16-001685","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71229.0,"shares_display":"71,229","price_per_share":33.3515455783459,"price_display":"33.35","price_state":"stated","total_value":2375597.24,"total_display":"2,375,597.24","total_whole":"2,375,597","shares_owned_after":355881.0,"shares_owned_after_display":"355,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-04","filed_date":"2016-02-08","scope":"insider","n_lines":7},{"id":8708860,"accession":"0001123292-15-001249","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001123292-15-001249","line_url":"/filing/0001123292-15-001249","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72352.0,"shares_display":"72,352","price_per_share":27.23502653693056,"price_display":"27.24","price_state":"stated","total_value":1970508.64,"total_display":"1,970,508.64","total_whole":"1,970,509","shares_owned_after":319593.0,"shares_owned_after_display":"319,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-15","filed_date":"2015-10-19","scope":"insider","n_lines":4},{"id":8242117,"accession":"0001123292-15-001198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-15-001198","line_url":"/filing/0001123292-15-001198#line-1","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2648.0,"shares_display":"2,648","price_per_share":22.0628,"price_display":"22.06","price_state":"stated","total_value":58422.2944,"total_display":"58,422.29","total_whole":"58,422","shares_owned_after":366945.0,"shares_owned_after_display":"366,945","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-21","filed_date":"2015-09-23","scope":"insider"},{"id":8940592,"accession":"0001123292-15-000963","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-15-000963","line_url":"/filing/0001123292-15-000963","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":24.67172936,"price_display":"24.67","price_state":"stated","total_value":1850379.702,"total_display":"1,850,379.70","total_whole":"1,850,380","shares_owned_after":294593.0,"shares_owned_after_display":"294,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-22","filed_date":"2015-06-24","scope":"insider","n_lines":2},{"id":7009716,"accession":"0001123292-14-001002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001123292-14-001002","line_url":"/filing/0001123292-14-001002#line-3","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7143.0,"shares_display":"7,143","price_per_share":13.1107,"price_display":"13.11","price_state":"stated","total_value":93649.7301,"total_display":"93,649.73","total_whole":"93,650","shares_owned_after":356503.0,"shares_owned_after_display":"356,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-04","filed_date":"2014-11-04","scope":"insider"},{"id":7009714,"accession":"0001123292-14-001002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-14-001002","line_url":"/filing/0001123292-14-001002#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13559.0,"shares_display":"13,559","price_per_share":13.0546,"price_display":"13.05","price_state":"stated","total_value":177007.3214,"total_display":"177,007.32","total_whole":"177,007","shares_owned_after":363646.0,"shares_owned_after_display":"363,646","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider"},{"id":7009711,"accession":"0001123292-14-001002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-14-001002","line_url":"/filing/0001123292-14-001002#line-1","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11901.0,"shares_display":"11,901","price_per_share":13.0873,"price_display":"13.09","price_state":"stated","total_value":155751.9573,"total_display":"155,751.96","total_whole":"155,752","shares_owned_after":377205.0,"shares_owned_after_display":"377,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-31","filed_date":"2014-11-04","scope":"insider"},{"id":6461632,"accession":"0001123292-14-000978","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001123292-14-000978","line_url":"/filing/0001123292-14-000978#line-3","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5838.0,"shares_display":"5,838","price_per_share":13.3229,"price_display":"13.32","price_state":"stated","total_value":77779.0902,"total_display":"77,779.09","total_whole":"77,779","shares_owned_after":389106.0,"shares_owned_after_display":"389,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-30","filed_date":"2014-10-30","scope":"insider"},{"id":6461629,"accession":"0001123292-14-000978","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-14-000978","line_url":"/filing/0001123292-14-000978#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1825.0,"shares_display":"1,825","price_per_share":13.032,"price_display":"13.03","price_state":"stated","total_value":23783.4,"total_display":"23,783.40","total_whole":"23,783","shares_owned_after":394944.0,"shares_owned_after_display":"394,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-29","filed_date":"2014-10-30","scope":"insider"},{"id":6461626,"accession":"0001123292-14-000978","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-14-000978","line_url":"/filing/0001123292-14-000978#line-1","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001475714","owner_name":"Williams Lewis T","owner_display_name":"Williams Lewis T","owner_url":"/insider/0001475714","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9734.0,"shares_display":"9,734","price_per_share":13.0379,"price_display":"13.04","price_state":"stated","total_value":126910.9186,"total_display":"126,910.92","total_whole":"126,911","shares_owned_after":396769.0,"shares_owned_after_display":"396,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-28","filed_date":"2014-10-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001377121","name":"Protagonist Therapeutics, Inc","url":"/issuer/0001377121","role":"Director","n_filings":1,"first_seen":"2026-02-18","last_seen":"2026-02-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001175505","name":"FIVE PRIME THERAPEUTICS INC","url":"/issuer/0001175505","role":"Director, Officer (President, CEO and Chairman)","n_filings":13,"first_seen":"2014-10-30","last_seen":"2016-12-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001475714","retrieved_at":"2026-08-22T20:06:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}